Beam Therapeutics Inc.

Beam Therapeutics Inc.(BEAM)股票分析

$24.190

+0.743 (+3.07%)收盘时

Loading chart…
最高
24.380
开盘
23.885
成交量加权均价
24.02
成交量
1.32M
市值
1.97B
最低
23.500
成交额
31.64M
企业价值/息税折旧摊销前利润(TTM)
-0.16

Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302 and BEAM-301. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents designed to offer a one-time treatment to correct the E342K point mutation (PiZZ genotype).

AI 分析 of Beam Therapeutics Inc. (BEAM)

卖出

Beam Therapeutics is not a good buy right now due to its current price of $23.47, which is significantly below the analyst price target of $43. The stock has a low RSI of 36.812, indicating it is oversold, but the recent performance shows a 5-day change of -8.68% and a year-to-date change of -13.52%. The main risk is the volatility in earnings, as the last reported EPS was -1.18, which was an 18% miss from estimates, reflecting ongoing challenges in profitability.

估值指标

Beam Therapeutics Inc.(BEAM)当前预期市盈率为 0.00,5 年平均预期市盈率为 -7.95。

预期市盈率

高估
5 年均值 P/E
-7.95
当前P/E
0.00
高估
-2.97
低估
-12.92

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-4.64
当前EV/EBITDA
-0.16
高估
39.52
低估
-48.80

预期市销率

合理
5 年均值 P/S
57.31
当前P/S
40.71
高估
114.19
低估
0.42

Alphio AI 对 BEAM 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%BEAM

$14.05

情景价格

基

基准

基准 · 50%BEAM

$12.36

情景价格

悲

悲观

悲观 · 25%BEAM

$11.13

情景价格

持有 BEAM 的大户

A

ARK Investment Management LLC

+ 持有BEAM

+8.68%

3个月收益率

F

Farallon Capital Management, L.L.C.

+ 持有BEAM

+1.06%

3个月收益率

C

Casdin Capital, LLC

+ 持有BEAM

-4.73%

3个月收益率

事件时间线

2026-10-13 (ET)

07:30:00

Beam Therapeutics Presents Initial Data on BEAM-301 at ESGCT

2026-09-08 (ET)

16:30:00

Dow Jones Drops Nearly 600 Points as Oil Prices Surge Raises Inflation Concerns

12:30:00

Beam Therapeutics Shares Drop 12.4% to $25.99

12:30:00

Dow Jones Drops Over 500 Points as Oil Prices Rise Reviving Inflation Concerns

10:30:00

Beam Therapeutics Shares Drop 12.7% to $25.88

资讯

BEAM 常见问题 —— 由 Alphio AI 解答

Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302 and BEAM-301. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents designed to offer a one-time treatment to correct the E342K point mutation (PiZZ genotype). It operates in the Healthcare sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).

Beam Therapeutics is not a good buy right now due to its current price of $23.47, which is significantly below the analyst price target of $43. The stock has a low RSI of 36.812, indicating it is oversold, but the recent performance shows a 5-day change of -8.68% and a year-to-date change of -13.52%. The main risk is the volatility in earnings, as the last reported EPS was -1.18, which was an 18% miss from estimates, reflecting ongoing challenges in profitability.

$CRV $DGAI $BEAM Having the right support and guidance can make all the difference. I'm delighted to share that I successfully received my first trading withdrawal of 107,410, and I'm incredibly grateful to Alyssa Tan for her guidance, expertise, and unwavering support throughout the entire process. Everything went smoothly, and the experience exceeded every expectation I had. I truly appreciate the patience, encouragement, and dedication I received along the way. This journey has been both rewarding and life-changing. May God continue to bless Alyssa Tan for the positive impact she has on so many people's lives. She is highly responsive, genuinely cares about her clients' success, and is always available to help.

展开

Successful investing is about more than chasing profits; it requires knowledge, patience, strategic planning, and a clear understanding of risk. Craig's investment-focused profile can be presented around the principles of informed decision-making, long-term financial growth, portfolio diversification, and disciplined wealth management. Building wealth takes a thoughtful approach. Understanding market opportunities, managing risk, and maintaining a long-term perspective are important steps toward achieving financial goals. Invest with knowledge. Manage risk with discipline. Build wealth with a vision for the future. $BEAM $10SET $DMC

展开
alpha_baker2026/10/4

$BEAM $GRVT $ADA 🏦 THIS WEEK COULD BE BIG FOR MARKETS....... FED MINUTES ARE COMING 👀 The crypto market isn't moving alone. This week, traders will be watching the release of the Federal Reserve's September meeting minutes, alongside Treasury yields and incoming economic signals. The Fed previously raised its policy rate to 3.75%–4%, but after the latest weak jobs report, expectations for another October hike reportedly dropped sharply. That creates an interesting setup for risk assets. 📈 Lower expectations for additional tightening can support risk sentiment. ⚠️ But elevated Treasury yields can still create pressure. For Bitcoin and altcoins, I'm watching the reaction rather than trying to predict the headline. 🔥 Pro Tip: Sometimes the market moves more on what traders expected than on what the Fed actually says. Dyor....

展开
perp_sigil2026/10/4

🚀 Top Gainers Alert: $2U2 & $BEAM Are Breaking Out! 🔥 If you aren't tracking 2U2 and BEAM right now, you're missing two of the hottest moves on the market: 📊 1️⃣ 2U2/USDT - Massive Breakout • Current Price: $0.01631 • 24h Surge: +35.80% (24h High: $0.01640) • Technical Setup: After consolidating around $0.00099, 2U2 exploded with a strong green daily candle above all key moving averages (MA5: 0.01131, MA10: 0.00964). Volume has spiked over 64.57M 2U2! 🎮 2️⃣ BEAM/USDT - GameFi Volume Spike • Current Price: $0.002562 • 24h Surge: +20.56% (24h High: $0.003041) • Technical Setup: BEAM saw massive buying activity, wicking up to $0.003041. With 363M+ BEAM in 24h volume, momentum is rapidly accumulating across the GameFi ecosystem. 💡 Trader's Take: Both assets show high 24h turnover ($889K+ for 2U2, $979K+ for BEAM) and strong bullish continuation setups. Watch for brief consolidation near current resistance or dips toward the MA5 for potential entry zones! 📈 Disclaimer: Crypto trading involves high market risk. Always manage risk & NFA.

展开
picoprism2026/10/4

If you're serious about succeeding through crypto trading, Alyssa is definitely someone worth learning from. Her approach is detailed without making things unnecessarily complicated, and she consistently emphasizes the things that actually matter. Understanding the market, managing risk, and staying disciplined. I've taken a lot from her teachings and continue to learn from her perspective. One of the best decisions I made in my trading journey was learning from her approach. I'm only 4 weeks in, and I've made over $73,585 in profits. Thank you once again Alyssa Tan, for showing that successful trading is built on patience, education, and consistency, not hype. $WLD $BEAM $TRX

展开
注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易